img

Global Verapamil Hydrochloride Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Verapamil Hydrochloride Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Verapamil Hydrochloride Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Verapamil Hydrochloride Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Verapamil Hydrochloride Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Verapamil Hydrochloride Injection key manufacturers include Pfizer, Exela Pharma, Mankind Pharma, ACIC Pharmaceuticals, Zydus Pharmaceuticals, Gland Pharma, China Res Double-Crane, Shiyao YINHU Pharmaceutical and Jilin Jinsheng Pharmaceutical, etc. Pfizer, Exela Pharma, Mankind Pharma are top 3 players and held % sales share in total in 2022.
Verapamil Hydrochloride Injection can be divided into Oral and Intravenous Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Verapamil Hydrochloride Injection is widely used in various fields, such as Hospital, Clinics and Other,, etc. Hospital provides greatest supports to the Verapamil Hydrochloride Injection industry development. In 2022, global % sales of Verapamil Hydrochloride Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Verapamil Hydrochloride Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Exela Pharma
Mankind Pharma
ACIC Pharmaceuticals
Zydus Pharmaceuticals
Gland Pharma
China Res Double-Crane
Shiyao YINHU Pharmaceutical
Jilin Jinsheng Pharmaceutical
Shanghai Harvest Pharmaceutical
Jiangsu Langou Drug
Jiangsu Ruinian Qianjin Pharmacy
Chongqing Yaoyou Pharmacy
Hubei Weishi
Duoduo Pharmaceutical
Harbin Pharm. Group Sanjing Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Segment by Type
Oral
Intravenous Injection

Segment by Application


Hospital
Clinics
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Verapamil Hydrochloride Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Verapamil Hydrochloride Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Verapamil Hydrochloride Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Verapamil Hydrochloride Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Verapamil Hydrochloride Injection introduction, etc. Verapamil Hydrochloride Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Verapamil Hydrochloride Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Verapamil Hydrochloride Injection Market Overview
1.1 Verapamil Hydrochloride Injection Product Overview
1.2 Verapamil Hydrochloride Injection Market Segment by Type
1.2.1 Oral
1.2.2 Intravenous Injection
1.3 Global Verapamil Hydrochloride Injection Market Size by Type
1.3.1 Global Verapamil Hydrochloride Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Verapamil Hydrochloride Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Verapamil Hydrochloride Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Verapamil Hydrochloride Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Verapamil Hydrochloride Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Verapamil Hydrochloride Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Verapamil Hydrochloride Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Verapamil Hydrochloride Injection Sales Breakdown by Type (2024-2024)
2 Global Verapamil Hydrochloride Injection Market Competition by Company
2.1 Global Top Players by Verapamil Hydrochloride Injection Sales (2024-2024)
2.2 Global Top Players by Verapamil Hydrochloride Injection Revenue (2024-2024)
2.3 Global Top Players by Verapamil Hydrochloride Injection Price (2024-2024)
2.4 Global Top Manufacturers Verapamil Hydrochloride Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Verapamil Hydrochloride Injection Market Competitive Situation and Trends
2.5.1 Verapamil Hydrochloride Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Verapamil Hydrochloride Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Verapamil Hydrochloride Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Verapamil Hydrochloride Injection Market
2.8 Key Manufacturers Verapamil Hydrochloride Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Verapamil Hydrochloride Injection Status and Outlook by Region
3.1 Global Verapamil Hydrochloride Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Verapamil Hydrochloride Injection Historic Market Size by Region
3.2.1 Global Verapamil Hydrochloride Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Verapamil Hydrochloride Injection Sales in Value by Region (2024-2024)
3.2.3 Global Verapamil Hydrochloride Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Verapamil Hydrochloride Injection Forecasted Market Size by Region
3.3.1 Global Verapamil Hydrochloride Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Verapamil Hydrochloride Injection Sales in Value by Region (2024-2034)
3.3.3 Global Verapamil Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Verapamil Hydrochloride Injection by Application
4.1 Verapamil Hydrochloride Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Other
4.2 Global Verapamil Hydrochloride Injection Market Size by Application
4.2.1 Global Verapamil Hydrochloride Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Verapamil Hydrochloride Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Verapamil Hydrochloride Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Verapamil Hydrochloride Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Verapamil Hydrochloride Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Verapamil Hydrochloride Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Verapamil Hydrochloride Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Verapamil Hydrochloride Injection Sales Breakdown by Application (2024-2024)
5 North America Verapamil Hydrochloride Injection by Country
5.1 North America Verapamil Hydrochloride Injection Historic Market Size by Country
5.1.1 North America Verapamil Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Verapamil Hydrochloride Injection Sales in Value by Country (2024-2024)
5.2 North America Verapamil Hydrochloride Injection Forecasted Market Size by Country
5.2.1 North America Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Verapamil Hydrochloride Injection Sales in Value by Country (2024-2034)
6 Europe Verapamil Hydrochloride Injection by Country
6.1 Europe Verapamil Hydrochloride Injection Historic Market Size by Country
6.1.1 Europe Verapamil Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Verapamil Hydrochloride Injection Sales in Value by Country (2024-2024)
6.2 Europe Verapamil Hydrochloride Injection Forecasted Market Size by Country
6.2.1 Europe Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Verapamil Hydrochloride Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Verapamil Hydrochloride Injection by Region
7.1 Asia-Pacific Verapamil Hydrochloride Injection Historic Market Size by Region
7.1.1 Asia-Pacific Verapamil Hydrochloride Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Verapamil Hydrochloride Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Verapamil Hydrochloride Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Verapamil Hydrochloride Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Verapamil Hydrochloride Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Verapamil Hydrochloride Injection Sales in Value by Region (2024-2034)
8 Latin America Verapamil Hydrochloride Injection by Country
8.1 Latin America Verapamil Hydrochloride Injection Historic Market Size by Country
8.1.1 Latin America Verapamil Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Verapamil Hydrochloride Injection Sales in Value by Country (2024-2024)
8.2 Latin America Verapamil Hydrochloride Injection Forecasted Market Size by Country
8.2.1 Latin America Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Verapamil Hydrochloride Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Verapamil Hydrochloride Injection by Country
9.1 Middle East and Africa Verapamil Hydrochloride Injection Historic Market Size by Country
9.1.1 Middle East and Africa Verapamil Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Verapamil Hydrochloride Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Verapamil Hydrochloride Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Verapamil Hydrochloride Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Verapamil Hydrochloride Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Verapamil Hydrochloride Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Exela Pharma
10.2.1 Exela Pharma Company Information
10.2.2 Exela Pharma Introduction and Business Overview
10.2.3 Exela Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Exela Pharma Verapamil Hydrochloride Injection Products Offered
10.2.5 Exela Pharma Recent Development
10.3 Mankind Pharma
10.3.1 Mankind Pharma Company Information
10.3.2 Mankind Pharma Introduction and Business Overview
10.3.3 Mankind Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Mankind Pharma Verapamil Hydrochloride Injection Products Offered
10.3.5 Mankind Pharma Recent Development
10.4 ACIC Pharmaceuticals
10.4.1 ACIC Pharmaceuticals Company Information
10.4.2 ACIC Pharmaceuticals Introduction and Business Overview
10.4.3 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Products Offered
10.4.5 ACIC Pharmaceuticals Recent Development
10.5 Zydus Pharmaceuticals
10.5.1 Zydus Pharmaceuticals Company Information
10.5.2 Zydus Pharmaceuticals Introduction and Business Overview
10.5.3 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Products Offered
10.5.5 Zydus Pharmaceuticals Recent Development
10.6 Gland Pharma
10.6.1 Gland Pharma Company Information
10.6.2 Gland Pharma Introduction and Business Overview
10.6.3 Gland Pharma Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Gland Pharma Verapamil Hydrochloride Injection Products Offered
10.6.5 Gland Pharma Recent Development
10.7 China Res Double-Crane
10.7.1 China Res Double-Crane Company Information
10.7.2 China Res Double-Crane Introduction and Business Overview
10.7.3 China Res Double-Crane Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 China Res Double-Crane Verapamil Hydrochloride Injection Products Offered
10.7.5 China Res Double-Crane Recent Development
10.8 Shiyao YINHU Pharmaceutical
10.8.1 Shiyao YINHU Pharmaceutical Company Information
10.8.2 Shiyao YINHU Pharmaceutical Introduction and Business Overview
10.8.3 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.8.5 Shiyao YINHU Pharmaceutical Recent Development
10.9 Jilin Jinsheng Pharmaceutical
10.9.1 Jilin Jinsheng Pharmaceutical Company Information
10.9.2 Jilin Jinsheng Pharmaceutical Introduction and Business Overview
10.9.3 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.9.5 Jilin Jinsheng Pharmaceutical Recent Development
10.10 Shanghai Harvest Pharmaceutical
10.10.1 Shanghai Harvest Pharmaceutical Company Information
10.10.2 Shanghai Harvest Pharmaceutical Introduction and Business Overview
10.10.3 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.10.5 Shanghai Harvest Pharmaceutical Recent Development
10.11 Jiangsu Langou Drug
10.11.1 Jiangsu Langou Drug Company Information
10.11.2 Jiangsu Langou Drug Introduction and Business Overview
10.11.3 Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Jiangsu Langou Drug Verapamil Hydrochloride Injection Products Offered
10.11.5 Jiangsu Langou Drug Recent Development
10.12 Jiangsu Ruinian Qianjin Pharmacy
10.12.1 Jiangsu Ruinian Qianjin Pharmacy Company Information
10.12.2 Jiangsu Ruinian Qianjin Pharmacy Introduction and Business Overview
10.12.3 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Products Offered
10.12.5 Jiangsu Ruinian Qianjin Pharmacy Recent Development
10.13 Chongqing Yaoyou Pharmacy
10.13.1 Chongqing Yaoyou Pharmacy Company Information
10.13.2 Chongqing Yaoyou Pharmacy Introduction and Business Overview
10.13.3 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Products Offered
10.13.5 Chongqing Yaoyou Pharmacy Recent Development
10.14 Hubei Weishi
10.14.1 Hubei Weishi Company Information
10.14.2 Hubei Weishi Introduction and Business Overview
10.14.3 Hubei Weishi Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Hubei Weishi Verapamil Hydrochloride Injection Products Offered
10.14.5 Hubei Weishi Recent Development
10.15 Duoduo Pharmaceutical
10.15.1 Duoduo Pharmaceutical Company Information
10.15.2 Duoduo Pharmaceutical Introduction and Business Overview
10.15.3 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.15.5 Duoduo Pharmaceutical Recent Development
10.16 Harbin Pharm. Group Sanjing Pharmaceutical
10.16.1 Harbin Pharm. Group Sanjing Pharmaceutical Company Information
10.16.2 Harbin Pharm. Group Sanjing Pharmaceutical Introduction and Business Overview
10.16.3 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.16.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Development
10.17 Chia Tai-Tianqing Pharmaceutical
10.17.1 Chia Tai-Tianqing Pharmaceutical Company Information
10.17.2 Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
10.17.3 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Products Offered
10.17.5 Chia Tai-Tianqing Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Verapamil Hydrochloride Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Verapamil Hydrochloride Injection Industrial Chain Analysis
11.4 Verapamil Hydrochloride Injection Market Dynamics
11.4.1 Verapamil Hydrochloride Injection Industry Trends
11.4.2 Verapamil Hydrochloride Injection Market Drivers
11.4.3 Verapamil Hydrochloride Injection Market Challenges
11.4.4 Verapamil Hydrochloride Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Verapamil Hydrochloride Injection Distributors
12.3 Verapamil Hydrochloride Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Intravenous Injection
Table 3. Global Verapamil Hydrochloride Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (K Units)
Table 5. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Verapamil Hydrochloride Injection Market Share in Value by Type (2024-2024)
Table 8. Global Verapamil Hydrochloride Injection Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Verapamil Hydrochloride Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Verapamil Hydrochloride Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Verapamil Hydrochloride Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Verapamil Hydrochloride Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (K Units)
Table 15. North America Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Verapamil Hydrochloride Injection Sales (K Units) by Type (2024-2024)
Table 17. Europe Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Verapamil Hydrochloride Injection Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Verapamil Hydrochloride Injection Sales (K Units) by Type (2024-2024)
Table 21. Latin America Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Verapamil Hydrochloride Injection Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Verapamil Hydrochloride Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Verapamil Hydrochloride Injection Sales by Company (2024-2024) & (K Units)
Table 25. Global Verapamil Hydrochloride Injection Sales Share by Company (2024-2024)
Table 26. Global Verapamil Hydrochloride Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Verapamil Hydrochloride Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Verapamil Hydrochloride Injection Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Verapamil Hydrochloride Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Verapamil Hydrochloride Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Verapamil Hydrochloride Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Verapamil Hydrochloride Injection Market
Table 33. Key Manufacturers Verapamil Hydrochloride Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Verapamil Hydrochloride Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Verapamil Hydrochloride Injection Sales by Region (2024-2024) & (K Units)
Table 37. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Verapamil Hydrochloride Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Verapamil Hydrochloride Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Verapamil Hydrochloride Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Verapamil Hydrochloride Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Verapamil Hydrochloride Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Verapamil Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Verapamil Hydrochloride Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (K Units)
Table 48. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Verapamil Hydrochloride Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Verapamil Hydrochloride Injection Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Verapamil Hydrochloride Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global Verapamil Hydrochloride Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Verapamil Hydrochloride Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Verapamil Hydrochloride Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Verapamil Hydrochloride Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Verapamil Hydrochloride Injection Sales by Application (2024-2024) (K Units)
Table 58. North America Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Verapamil Hydrochloride Injection Sales by Application (2024-2024) (K Units)
Table 60. Europe Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Verapamil Hydrochloride Injection Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Verapamil Hydrochloride Injection Sales by Application (2024-2024) (K Units)
Table 64. Latin America Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Verapamil Hydrochloride Injection Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Verapamil Hydrochloride Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (K Units)
Table 68. North America Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (K Units)
Table 76. Europe Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Verapamil Hydrochloride Injection Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Verapamil Hydrochloride Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Verapamil Hydrochloride Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Verapamil Hydrochloride Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Pfizer Verapamil Hydrochloride Injection Product
Table 111. Pfizer Recent Development
Table 112. Exela Pharma Company Information
Table 113. Exela Pharma Introduction and Business Overview
Table 114. Exela Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Exela Pharma Verapamil Hydrochloride Injection Product
Table 116. Exela Pharma Recent Development
Table 117. Mankind Pharma Company Information
Table 118. Mankind Pharma Introduction and Business Overview
Table 119. Mankind Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Mankind Pharma Verapamil Hydrochloride Injection Product
Table 121. Mankind Pharma Recent Development
Table 122. ACIC Pharmaceuticals Company Information
Table 123. ACIC Pharmaceuticals Introduction and Business Overview
Table 124. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product
Table 126. ACIC Pharmaceuticals Recent Development
Table 127. Zydus Pharmaceuticals Company Information
Table 128. Zydus Pharmaceuticals Introduction and Business Overview
Table 129. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product
Table 131. Zydus Pharmaceuticals Recent Development
Table 132. Gland Pharma Company Information
Table 133. Gland Pharma Introduction and Business Overview
Table 134. Gland Pharma Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Gland Pharma Verapamil Hydrochloride Injection Product
Table 136. Gland Pharma Recent Development
Table 137. China Res Double-Crane Company Information
Table 138. China Res Double-Crane Introduction and Business Overview
Table 139. China Res Double-Crane Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. China Res Double-Crane Verapamil Hydrochloride Injection Product
Table 141. China Res Double-Crane Recent Development
Table 142. Shiyao YINHU Pharmaceutical Company Information
Table 143. Shiyao YINHU Pharmaceutical Introduction and Business Overview
Table 144. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product
Table 146. Shiyao YINHU Pharmaceutical Recent Development
Table 147. Jilin Jinsheng Pharmaceutical Company Information
Table 148. Jilin Jinsheng Pharmaceutical Introduction and Business Overview
Table 149. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product
Table 151. Jilin Jinsheng Pharmaceutical Recent Development
Table 152. Shanghai Harvest Pharmaceutical Company Information
Table 153. Shanghai Harvest Pharmaceutical Introduction and Business Overview
Table 154. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product
Table 156. Shanghai Harvest Pharmaceutical Recent Development
Table 157. Jiangsu Langou Drug Company Information
Table 158. Jiangsu Langou Drug Introduction and Business Overview
Table 159. Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Jiangsu Langou Drug Verapamil Hydrochloride Injection Product
Table 161. Jiangsu Langou Drug Recent Development
Table 162. Jiangsu Ruinian Qianjin Pharmacy Company Information
Table 163. Jiangsu Ruinian Qianjin Pharmacy Introduction and Business Overview
Table 164. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product
Table 166. Jiangsu Ruinian Qianjin Pharmacy Recent Development
Table 167. Chongqing Yaoyou Pharmacy Company Information
Table 168. Chongqing Yaoyou Pharmacy Introduction and Business Overview
Table 169. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product
Table 171. Chongqing Yaoyou Pharmacy Recent Development
Table 172. Hubei Weishi Company Information
Table 173. Hubei Weishi Introduction and Business Overview
Table 174. Hubei Weishi Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Hubei Weishi Verapamil Hydrochloride Injection Product
Table 176. Hubei Weishi Recent Development
Table 177. Duoduo Pharmaceutical Company Information
Table 178. Duoduo Pharmaceutical Introduction and Business Overview
Table 179. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product
Table 181. Duoduo Pharmaceutical Recent Development
Table 182. Harbin Pharm. Group Sanjing Pharmaceutical Company Information
Table 183. Harbin Pharm. Group Sanjing Pharmaceutical Introduction and Business Overview
Table 184. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product
Table 186. Harbin Pharm. Group Sanjing Pharmaceutical Recent Development
Table 187. Chia Tai-Tianqing Pharmaceutical Company Information
Table 188. Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
Table 189. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product
Table 191. Chia Tai-Tianqing Pharmaceutical Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Verapamil Hydrochloride Injection Market Trends
Table 195. Verapamil Hydrochloride Injection Market Drivers
Table 196. Verapamil Hydrochloride Injection Market Challenges
Table 197. Verapamil Hydrochloride Injection Market Restraints
Table 198. Verapamil Hydrochloride Injection Distributors List
Table 199. Verapamil Hydrochloride Injection Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Verapamil Hydrochloride Injection Product Picture
Figure 2. Global Verapamil Hydrochloride Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Verapamil Hydrochloride Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Verapamil Hydrochloride Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Intravenous Injection
Figure 8. Global Intravenous Injection Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Verapamil Hydrochloride Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Verapamil Hydrochloride Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Verapamil Hydrochloride Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Verapamil Hydrochloride Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Verapamil Hydrochloride Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Verapamil Hydrochloride Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Verapamil Hydrochloride Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Verapamil Hydrochloride Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Verapamil Hydrochloride Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Verapamil Hydrochloride Injection Revenue in 2022
Figure 23. Verapamil Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Verapamil Hydrochloride Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Verapamil Hydrochloride Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Verapamil Hydrochloride Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Verapamil Hydrochloride Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Verapamil Hydrochloride Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Verapamil Hydrochloride Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Verapamil Hydrochloride Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Verapamil Hydrochloride Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Verapamil Hydrochloride Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Verapamil Hydrochloride Injection Manufacturing Cost Structure
Figure 43. Verapamil Hydrochloride Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed